CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 443 filers reported holding CRISPR THERAPEUTICS AG in Q4 2021. The put-call ratio across all filers is 1.13 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,088,718 | -16.5% | 112,111 | +3.3% | 0.00% | 0.0% |
| Q2 2023 | $6,090,854 | -46.4% | 108,494 | -56.8% | 0.00% | -50.0% |
| Q1 2023 | $11,353,409 | +36.3% | 251,015 | +22.5% | 0.01% | +14.3% |
| Q4 2022 | $8,331,137 | -38.3% | 204,948 | -0.8% | 0.01% | -22.2% |
| Q3 2022 | $13,501,000 | +143.4% | 206,594 | +126.4% | 0.01% | +125.0% |
| Q2 2022 | $5,546,000 | +190.7% | 91,254 | +200.4% | 0.00% | +300.0% |
| Q1 2022 | $1,908,000 | -18.2% | 30,378 | -1.3% | 0.00% | 0.0% |
| Q4 2021 | $2,332,000 | -26.9% | 30,788 | +8.0% | 0.00% | -50.0% |
| Q3 2021 | $3,192,000 | -40.5% | 28,513 | -14.0% | 0.00% | -33.3% |
| Q2 2021 | $5,368,000 | +69.3% | 33,161 | +27.4% | 0.00% | +50.0% |
| Q1 2021 | $3,171,000 | -89.8% | 26,026 | -87.2% | 0.00% | -89.5% |
| Q4 2020 | $31,183,000 | +211.5% | 203,661 | +70.1% | 0.02% | +171.4% |
| Q3 2020 | $10,012,000 | -25.4% | 119,712 | -34.4% | 0.01% | -36.4% |
| Q2 2020 | $13,413,000 | +38.0% | 182,514 | -20.4% | 0.01% | +22.2% |
| Q1 2020 | $9,720,000 | +6.8% | 229,203 | +53.4% | 0.01% | +50.0% |
| Q4 2019 | $9,098,000 | +195.0% | 149,378 | +98.5% | 0.01% | +200.0% |
| Q3 2019 | $3,084,000 | -17.3% | 75,243 | -5.0% | 0.00% | -50.0% |
| Q2 2019 | $3,730,000 | +110.4% | 79,190 | +59.5% | 0.00% | +100.0% |
| Q1 2019 | $1,773,000 | +34.8% | 49,656 | +8.0% | 0.00% | +100.0% |
| Q4 2018 | $1,315,000 | +38.7% | 45,998 | +115.0% | 0.00% | – |
| Q3 2018 | $948,000 | +59.3% | 21,395 | +111.5% | 0.00% | -100.0% |
| Q2 2018 | $595,000 | +875.4% | 10,117 | +665.3% | 0.00% | – |
| Q1 2018 | $61,000 | +103.3% | 1,322 | +1.3% | 0.00% | – |
| Q4 2017 | $30,000 | – | 1,305 | +12950.0% | 0.00% | – |
| Q3 2017 | $0 | -100.0% | 10 | -90.0% | 0.00% | – |
| Q1 2017 | $2,000 | – | 100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 498,558 | $31,294,000 | 31.24% |
| NEA Management Company, LLC | 1,590,002 | $365,593,000 | 10.56% |
| Ariose Capital Management Ltd | 37,900 | $2,379,000 | 9.30% |
| ARK Investment Management | 9,404,071 | $590,294,000 | 2.46% |
| NIA IMPACT ADVISORS, LLC | 80,082 | $5,027,000 | 2.44% |
| Nikko Asset Management Americas, Inc. | 4,619,747 | $291,044,000 | 2.14% |
| PLUSTICK MANAGEMENT LLC | 50,000 | $3,139,000 | 1.98% |
| Integral Health Asset Management, LLC | 120,000 | $7,532,000 | 1.96% |
| Valiant Capital Management, L.P. | 240,683 | $15,108,000 | 1.73% |
| Deuterium Capital Management, LLC | 18,000 | $1,130,000 | 1.45% |